Technetium 99m-labeled tetrofosmin and iodine 123-labeled metaiodobenzylguanidine scintigraphy in the assessment of transmyocardial laser revascularization

Journal of Thoracic and Cardiovascular Surgery

Volumn 125, Issue 6, 2003, Pages 1493-1498

  Muxí, Africa ^a,b,d   Magriñá, Jordi ^c   Martín, Francisco ^a   Josa, Miguel ^c   Fuster, David ^a,b   Setoain, Francisco J ^a   Pérez Villa, Félix ^c   Pavía, Javier ^a,b   Bosch, Xavier ^b,c  

^a Institut de Diagnostic per la Imatge   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c Inst de Malalties Cardiovasculars   (Spain)

^d HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

(3 IODOBENZYL)GUANIDINE; IODINE 123; TETROFOSMIN TC 99M;

ADULT; AGED; ANGINA PECTORIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CONVALESCENCE; CORONARY ARTERY DISEASE; FEMALE; FOLLOW UP; HEART MUSCLE; HEART MUSCLE PERFUSION; HEART MUSCLE REVASCULARIZATION; HUMAN; INNERVATION; MALE; PRIORITY JOURNAL; REVASCULARIZATION; SCINTIGRAPHY; STRESS; SYMPTOMATOLOGY; TREATMENT OUTCOME; TREATMENT PLANNING;

EID: 0037973293     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5223(02)73271-6     Document Type: Article

References (24)

1. Hughes GC, Landolfo KP, Lowe JE, Coleman RB, Donovan CL. Perioperative morbidity and mortality after Trasnsmyocardial laser revascularization: incidence and risk factors for adverse events. J Am Coll Cardiol. 1999;33:1021-6.
2. Allen KB, Dowling RD, Fudge TL, Schoettle GP, Selinger SL, Gangahar DM, et al. Comparison of transmyocardial laser revascularization with medical therapy in patients with refractory angina. N Engl J Med. 1999;341:1029-36.
3. Al-Sheikh T, Allen KB, Straka SP, Heimansohn DA, Fain RL, Hutchins GD, et al. Cardiac sympathetic denervation after transmyocardial laser revascularization. Circulation. 1999;100:135-40.
4. Henderson EB, Kahn JK, Corbett JR, Jansen DE, Pippin JJ, Kulkarni P, et al. Abnormal 1-123 metaiodobenzylguanidine myocardial wash-out and distribution may reflect myocardial adrenergic derangement in patients with congestive myopathy. Circulation. 1988;78:1192-9.
5. Schäfers M, Wichter T, Lerch H, Matheja P, Kuvert T, Shäfers K, et al. Cardiac 1231-MIBG uptake in idiopathic ventricular tachycardia and fibrilation. J Nucl Med. 1999;40:1-5.
6. Cooley DA, Frazier OH, Kadipasaoglu KA, Lindenmeier MH, Pehlivanoglu S, KolffJW, et al. Transmyocardial laser revascularization: clinical experience with twelve-months follow-up. J Thorac Cardiovasc Surg. 1996;111:791-9.
7. Horvath KA, Cohn LH, Cooley DA, Crew JR, Frazier OH, Griffith BP, et al. Transmyocardial laser revascularization: results of a multicenter trial with transmyocardial laser revascularization used as a sole therapy for end-stage coronary artery disease. J Thorac Cardiovasc Surg. 1997;113:645-54.
8. Schofield PM, Sharples LD, Caine N, Burns S, Tait S, Wistow T. et al. Transmyocardial laser revascularization in patients with refractory angina: a randomised controlled trial. Lancet. 1999;353:519-24.
9. De Carlo M, Milano AD, Pratali S, Levantino M, Mariotti R, Bortolotti U. Symptomatic improvement after transmyocardial laser revascularization: how long does it last? Ann Thorac Surg. 2000;70:1130-3.
10. Schneider J, Diegler A, Krakor R, Walther T, Kluge R, Mohr FW. Transmyocardial laser revascularization with the holmium: YAG laser: loss of symptomatic improvement after 2 years. Eur J Cardiothorac Surg. 2001;19:164-9.
11. Frazier OH, March RJ, Horvath KA. Transmyocardial revascularization with a carbon dioxide laser in patients with end-stage coronary artery disease. N Engl J Med. 1999;341:1021-8.
12. Yamamoto N, Kohmoto T, Gu A, DeRosa C, Smith CR, Burkoff D. Angiogenesis is enhanced in ischemic canine myocardium by transmyocardial laser revascularization. J Am Coll Cardiol. 1998:31: 1426-33.
13. Kohmoto T, DeRosa CM, Yamamoto N, Fisher PE, Failey P, Smith CR, et al. Evidence of vascular growth associated with laser treatment of normal canine myocardium. Ann Thorac Surg. 1998;65:1360-7.
14. Diegeler A, Schneider J, Lauer B, Mohr FW, Kluge R. Transmyocardium laser revascularization using the holmium-YAG laser for treatment of end stage coronary disease. Eur Cardiothorac Surg. 1998;13: 392-7.
15. Chu V, Giaid A, Kuang JQ, Mcginn A, Li C, Pelletier M, et al. Transmyocardial laser revascularization induced angiogenic response [abstract]. J Am Coll Cardiol. 1999;33(suppl A):342A.
16. Burkhoff D, Schmidt SH, Schulman SP, Myers J, Resar J, Becker L, et al. Transmyocardial Laser revascularization compared with continued medical therapy for treatment of refractory angina pectoris: a prospective randomised trial. Lancet. 1999;354:885-90.
17. Hamawy AH, Lee Ly, Samy SA, Polce DR, Szulc M, Vazquez M, et al. Transmyocardial laser revascularization dose response: enhance perfusion in a porcine ischaemia model as a function of channel density. Ann Thorac Surg. 2001;72:817-22.
18. Kwong KF, Kanellopoulos GK, Nickols JC, Pogwizd SM, Saffitz JE, Schuessler RB, et al. Transmyocardial laser treatment denervates canine myocardium. J Thorac Cardiovasc Surg. 1997;114:883-90.
19. Cohen-Solal A, Esanu Y, Logeart D, Pessione F, Dubois C, Dreyfus G, et al. Cardiac metaiodobenzylguanidine uptake in patients with moderate chronic heart failure: relationship with peak oxygen uptake and prognosis. J Am Coll Cardiol. 1999;33:759-66.
20. McGuie AL, Corbett JR, Akers MS, Kukkarni P, Sills MN, Kremers M, et al. Regional cardiac adrenergic function using I-123 metaiodobenzylguanidine tomographic imaging after acute myocardial infarction. Am J Cardiol. 1991;67:236-42.
21. Estorch M, Flotats A, Mari C, Catafau AM, Berna LL, Serra R, et al. Regional myocardial MIBG uptake at rest relates to regional perfusion at exercise in patients with CAD [abstract]. Eur J Nucl Med. 1998; 25:1003.
22. Estorch M, Campreciós M, Flotats A, Marí C, Berná L, Catafau AM, et al. Sympathetic reinervation of cardiac allograft evaluated by 1231-MIBG imaging. J Nucl Med. 1999;40:911-6.
23. Lee LY, Lee KT, Woo CS, Polce DR, Hachamovitch R, Sculz M, et al. TMR dose response: evidence of enhanced perfusion in porcine ischemic model after 50 vs. 10 channel TMR [abstract]. Circulation. 1999;100(suppl 18):1-247.
24. Solanki KK, Bomanji J, Moyes J, Mather SJ, Trainer PJ, Britton KE. A pharmacological guide to medicines which interfere with the biodistribution of radiolabelled metaiodobenzylguanidine (MIBG). Nucl Med Commun. 1992;13:513-21.